Reducing Nicotine in Cigarettes: Is It Time to Enable/Nudge/Push Smokers to Move Away from the Most Deadly Tobacco Products?
Eric C. Donny, Ph.D.
Professor
Department of Physiology and Pharmacology
School of Medicine
Wake Forest University
Virtual Pioneers in Biomedical Research Seminar: Reducing Nicotine in Cigarettes: Is It Time to Enable/Nudge/Push Smokers to Move Away from the Most Deadly Tobacco Products?
About this Seminar
Nicotine is the primary constituent in cigarettes driving the acquisition and maintenance of smoking behavior. The Biden Administration recently announced its intention to pursue a low nicotine product standard for cigarettes and other combusted tobacco products, reviving a pillar of the Comprehensive Framework for Nicotine and Tobacco Regulation announced in 2017. A similar approach is moving forward in New Zealand. Dr. Donny's seminar will review the science underlying nicotine reduction and discuss ways to optimize the likelihood that mandating very low nicotine levels in smoked tobacco will achieve the intended public health outcomes.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Addiction Recovery Research Center and the Center for Health Behaviors Research. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home ItemClinical Applications of Cancer Genetics , home
Nov. 21, 2024, 5:30 p.m. (Reception at 5 p.m.) | Luis Diaz, Jr., M.D., Head, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center; Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture
-
Home ItemA Ribocentric View of Muscle Proteostasis in Health and Disease: Novel Mechanisms Potential Therapeutic Opportunities , home
Nov. 22, 2024, 11:00 a.m. | Gustavo A. Nader, Ph.D., FAPS, Professor, College of Health and Human Development; Chair, Molecular, Cellular, and Integrative Physiology; Huck Institutes of the Life Sciences; The Pennsylvania State University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home ItemHuman Laboratory Evaluation of Cannabis Products , home
Dec. 13, 2024, 11:00 a.m. | Ryan Vandrey, Ph.D., Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and the Addiction Recovery Research Center
-
Home ItemMechanics of Convective Cell Motion , home
Jan. 10, 2025, 11:00 a.m. | Michael Murrell, Ph.D., Associate Professor, Department of Biomedical Engineering and Physics, Yale University | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke
-
Home ItemThe Role of Pericytes in Pulmonary Vascular Diseases , home
Jan. 17, 2025, 11:00 a.m. | Vinicio de Jesus Perez, M.D., FCCP, FAHA, Assistant Professor, Wall Center Adult PH Clinic Division of Pulmonary and Critical Care Medicine, Stanford School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home ItemRethinking Human Health with AI: Solving Old Mysteries with Modern Tools , home
Jan. 23, 2025, 5:30 p.m. (Reception at 5 p.m.) | Regina Barzilay, Ph.D., School of Engineering Distinguished Professor for AI and Health; AI Faculty Lead, Jameel Clinic; MIT Computer Science & Artificial Intelligence Lab; MacArthur Fellow; Member, National Academy of Engineering, American Academy of Arts and Sciences, and the National Academy of Medicine | Maury Strauss Distinguished Public Lecture